gout and semaglutide Weight Loss After Receiving Anti‐Obesity Medications Among Individuals With Overweight and Obese: A Population‐Based Cohort Study - Wei - 2025 - Arthritis & Rheumatology GLP-1 Drugs Could Raise the

Tirzepatide turns on both GLP-1 and GIP receptors, which work together to make insulin work better and keep the metabolism in check

Discover the research Description The AHK-Cu + GHK-Cu Peptide blend combines two copper peptides in a single topical spray formulation

Can Retatrutide be used as a weight loss product

Oral magnesium supplementation improves vascular function in elderly diabetic patients

The REDEFINE 4 trial (NCT06131437) failed to meet its primary endpoint of demonstrating non-inferiority in weight loss for CagriSema versus Zepbound at 84 weeks

As a phase 2 dose-ranging study, this trial was not designed to provide the definitive efficacy evidence required for regulatory submission